Sign In
Buy MNPR
$60.56
-0.700 (-1.14%)
At Close: Jun 03, 2026
Monopar Therapeutics Inc. (MNPR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
11:05am, Monday, 29'th May 2023
After losing some value lately, a hammer chart pattern has been formed for Monopar Therapeutics Inc. (MNPR), indicating that the stock has found support. This, combined with an upward trend in earning
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
03:00pm, Wednesday, 29'th Mar 2023 Benzinga
Upgrades
According to Sidoti & Co., the prior rating for Federal Agricultural Mortgage Corp (NYSE:AGM) was changed from Neutral to Buy. In the fourth quarter, Federal Agricultural showed an EPS of $3.
Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results
06:51pm, Tuesday, 28'th Mar 2023 Benzinga
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 90 points on Tuesday.
The Dow traded down 0.21% to 32,362.74 while the NASDAQ fell 0.77% to 11,678.39. Th
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
05:04pm, Tuesday, 28'th Mar 2023 Benzinga
Gainers
Biomea Fusion, Inc. (NASDAQ: BMEA) surged 56.8% to $24.20 after the company announced data from the initial cohorts of the ongoing Phase II study of BMF-219 in patients with type 2 diabetes;
Alibaba shares surge, Carnival’s stock rallies, and other stocks on the move
04:40pm, Tuesday, 28'th Mar 2023 MarketWatch
Here are some of the biggest movers Tuesday in a session when banking names seemed to calm down after making wild swings over the past few weeks.
Dow Rises 50 Points; Harmony Biosciences Shares Plunge
04:24pm, Tuesday, 28'th Mar 2023 Benzinga
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 50 points on Tuesday.
The Dow traded up 0.16% to 32,484.24 while the NASDAQ fell 0.75% to 11,681.12. The S&P 500, als
Monopar Therapeutics Shares Are Tumbling: What's Going On?
02:19pm, Tuesday, 28'th Mar 2023 Benzinga
Monopar Therapeutics Inc (NASDAQ: MNPR) shares are plunging in early trading Tuesday after the company announced it will discontinue the active development of Validive after being informed recent
Monopar to Present at the Jefferies Radiopharma Innovation Summit
11:00am, Tuesday, 28'th Mar 2023 GlobeNewswire Inc.
WILMETTE, Ill., March 28, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to ext
Why Is Monopar Therapeutics (MNPR) Stock Down 47% Today?
09:19am, Tuesday, 28'th Mar 2023
Monopar Therapeutics (NASDAQ: MNPR ) stock is taking a beating on Tuesday after the company revealed lackluster clinical trial results. These results come from the company's Validive Phase 2b/3 VOICE
Monopar to Present at the Jefferies Radiopharma Innovation Summit
07:00am, Tuesday, 28'th Mar 2023
WILMETTE, Ill., March 28, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to exten
Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis
09:00pm, Monday, 27'th Mar 2023 GlobeNewswire Inc.
WILMETTE, Ill., March 27, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to ex
Monopar to Present at the 35th Annual Roth Conference
12:00pm, Tuesday, 07'th Mar 2023 GlobeNewswire Inc.
WILMETTE, Ill., March 07, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to ext
Monopar to Present at the 35th Annual Roth Conference
07:00am, Tuesday, 07'th Mar 2023
WILMETTE, Ill., March 07, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to exten
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
12:45pm, Monday, 27'th Feb 2023 Benzinga
Gainers
Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses.
Ob
Monopar and NorthStar Announce Expanded Radiopharma Program, Positive Preclinical Results, and Visibility Toward Human Trials
12:00pm, Monday, 27'th Feb 2023 GlobeNewswire Inc.
WILMETTE, Ill. and BELOIT, Wis., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Wilmette, Ill.) and NorthStar Medical Radioisotopes, LLC (Beloit, Wis.), today announce
